Scorpius Holdings Inc (SCPX)

NYSEAMERICAN: SCPX · IEX Real-Time Price · USD
0.162
-0.002 (-1.10%)
At close: Mar 28, 2024, 4:00 PM
0.166
+0.004 (2.35%)
After-hours: Mar 28, 2024, 7:43 PM EDT

Company Description

Scorpius Holdings Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization.

The company provides analytical testing, downstream process development, formulation optimization and development, and clinical biomanufacturing services to pharmaceutical and biotech companies.

It is also involved in the provision of pre-clinical and product development; chemistry, manufacturing, and control analytical support; and bioassays.

The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024.

Scorpius Holdings, Inc. was incorporated in 2008 and is based in Morrisville, North Carolina.

Scorpius Holdings Inc
Scorpius Holdings logo
Country United States
Founded 2008
IPO Date Jul 24, 2013
Industry Biotechnology
Sector Healthcare
Employees 77
CEO Jeffrey Wolf

Contact Details

Address:
627 Davis Drive, Suite 400
Morrisville, North Carolina 27560
United States
Phone 919-240-7133

Stock Details

Ticker Symbol SCPX
Exchange NYSEAMERICAN
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001476963
Employer ID 26-2844103
SIC Code 2834

Key Executives

Name Position
Jeffrey Alan Wolf J.D. Founder, Chairman of the Board, Chief Executive Officer and President
William L. Ostrander Chief Financial Officer and Secretary
Dr. Justin Stebbing FRCP, FRCPath, M.A., M.D., Ph.D. Chief Medical Advisor and Member of Scientific and Clinical Advisory Board
Colonel George E. Peoples Jr., F.A.C.S., M.D. Chief Medical Advisor
Ania Szymanska Head of Quality
Joe Payne President and Chief Operating Officer of Scorpius BioManufacturing

Latest SEC Filings

Date Type Title
Mar 13, 2024 8-A12B/A Filing
Mar 13, 2024 8-K Current Report
Mar 11, 2024 8-K Current Report
Mar 11, 2024 424B5 Filing
Mar 7, 2024 FWP Free Writing Prospectus
Mar 7, 2024 424B5 Filing
Mar 7, 2024 424B5 Filing
Mar 7, 2024 8-K Current Report
Feb 6, 2024 8-K Current Report
Jan 30, 2024 8-K Current Report